Empresa Ocugen, Inc. Börse Stuttgart
Acciones
2H51
US67577C1053
Biotecnología e investigación médica
Tiempo real estimado
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
1,694 EUR | -3,86 % |
|
+7,50 % | +220,95 % |
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Shankar Musunuri
CEO | Chief Executive Officer | 60 | 01/01/13 |
Director of Finance/CFO | 42 | - | |
Jesse Simmers
CTO | Chief Tech/Sci/R&D Officer | - | - |
Huma Qamar
CTO | Chief Tech/Sci/R&D Officer | - | - |
Nirdosh Jagota
CMP | Compliance Officer | - | - |
Arun Upadhyay
CTO | Chief Tech/Sci/R&D Officer | - | 01/02/17 |
J.P. Gabriel
PRN | Corporate Officer/Principal | - | - |
Michael Shine
PRN | Corporate Officer/Principal | - | 10/06/21 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Director/Board Member | 76 | 17/03/22 | |
Director/Board Member | 74 | 05/04/20 | |
Shankar Musunuri
CEO | Chief Executive Officer | 60 | 01/01/13 |
Uday Kompella
FOU | Founder | 57 | 01/01/13 |
Junge Zhang
BRD | Director/Board Member | 57 | 01/09/19 |
Kirsten Castillo
BRD | Director/Board Member | 51 | 05/04/20 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 257 475 966 | 253 282 714 ( 98,37 %) | 121 500 ( 0,0472 %) | 98,37 % |
Acción B | 0 | 54 745 | 0 | 0 |
Información de la empresa
![Dirección Ocugen, Inc.(2H51)](https://cdn.zonebourse.com/static/address/50919212.png)
Sector
![Consenso](/images/consensus_flch.gif)
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+25,83 % | 47,96 mil M | |
+44,70 % | 41,47 mil M | |
+0,69 % | 42,45 mil M | |
+30,52 % | 31,6 mil M | |
+22,30 % | 28,63 mil M | |
-6,35 % | 28,03 mil M | |
+49,25 % | 14,56 mil M | |
+49,18 % | 14,14 mil M | |
+3,45 % | 12,58 mil M |
- Bolsa de valores
- Acciones
- Acción OCGN
- Acción 2H51
- Empresa Ocugen, Inc.